Abstract Library

#4628 Triple negative breast neuroendocrine carcinoma in older patient: A rare entity

Introduction: Neuroendocrine breast carcinoma is a rare histological form of breast cancer, that represent 0.1% of all breast cancers and is recognised by the World Health Organization as a distinct entity. Characterised by a non-specific clinical and radiological presentation. Therapeutic management is not codified and is usually superimposed on that of classical breast cancer.

Conference:

Presenting Author:

Authors: Aris H, Saidi M, Lahfa I,

Keywords: neuroendocrine carcinoma, triple negative breast cancer, platinum-based combination therapy,

#4554 Base on deep learning-integrated multimodal diagnostic framework for enhanced early detection of neuroendocrine tumours

Introduction: Neuroendocrine tumours (NETs) are a heterogeneous group of malignant neoplasms originating from neuroendocrine cells, commonly found in the digestive system, lungs, pancreas, and other organs. Due to their diverse clinical presentations and overlap with common diseases, the early diagnosis of NETs is challenging, often leading to misdiagnosis or delayed diagnosis at advanced stages.

Conference:

Presenting Author:

Authors: Ding Z, Li H, Tang Z, Chen Y, Li H,

Keywords: Neuroendocrine Tumour, Early Disease Screening, Multimodal Medical Data Analysis,

#4512 A deep learning-integrated multimodal diagnostic framework for enhanced early detection of neuroendocrine tumours

Introduction: Neuroendocrine tumours (NETs) are a heterogeneous group of malignant neoplasms originating from neuroendocrine cells, commonly found in the digestive system, lungs, pancreas, and other organs. Due to their diverse clinical presentations and overlap with common diseases, the early diagnosis of NETs is challenging, often leading to misdiagnosis or delayed diagnosis at advanced stages. While current imaging techniques and biomarkers are useful in certain cases, their diagnostic sensitivity and specificity remain limited when used in isolation.

Conference:

Presenting Author:

Authors: Ding Z, Li H, Tang Z, Chen Y, Li H,

Keywords: Neuroendocrine Tumour, Multimodal Diagnostic algorithm, Deep Learning, Early Disease Screening,

#4469 Therapeutic strategy for pancreatic neuroendocrine tumours: An overview of the TNE West Network (2016-2024)

Introduction: Neuroendocrine tumours (NETs) are relatively rare and often diagnosed at an advanced stage, typically occurring between the ages of 40 and 60. They primarily manifest in the gastrointestinal system, pancreas, bronchi, lungs, thymus, and thyroid.

Conference:

Presenting Author: Bengueddach A

Authors: Bengueddache A, Kehili H, Tidjane A, Tabeti B, Manouni C,

Keywords: neuroendocrine tumour, metastasis, somatostatin analogue, pancreas,

#4422 A case report of an undifferentiated neuroendocrine carcinoma with an unknown primary site

Introduction: In the situation where the primary lesion remains unknown, high-grade poorly differentiated neuroendocrine carcinoma typically shows extensive metastasis at the time of clinical visit. Common metastatic sites include the liver, bones, lungs and brain, and the prognosis is extremely poor.

Conference:

Presenting Author:

Authors: Lv J, Tang Y,

Keywords: poorly differentiated neuroendocrine carcinoma, unknown primary origin,